Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C33H46O4 |
| Molecular Weight | 506.7159 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCOC1=CC=C(CCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCC5=CC(=O)CC[C@@H]5[C@H]4CC[C@]23C)C=C1
InChI
InChIKey=PQKRYXHYWWQULJ-JMKYFRMNSA-N
InChI=1S/C33H46O4/c1-3-4-5-6-21-36-26-12-7-23(8-13-26)9-18-32(35)37-31-17-16-30-29-14-10-24-22-25(34)11-15-27(24)28(29)19-20-33(30,31)2/h7-8,12-13,22,27-31H,3-6,9-11,14-21H2,1-2H3/t27-,28+,29+,30-,31-,33-/m0/s1
| Molecular Formula | C33H46O4 |
| Molecular Weight | 506.7159 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Nandrolone hexyloxyphenylpropionate (brand names Anador, Anadur, Anadurine) is a synthetic androgen and anabolic steroid is marketed in some countries. Nandrolone, in general, is more anabolic than testosterone and has a very low androgenic expression. It is reported to have an anabolic to androgenic ratio of 37:125. Typically, males would take a dosage range of 200-600mg/wk with higher doses sometimes found in more advanced users. This compound normally would not be recommended for women due to the virilization effects this compound may cause such as increased body hair, deepened voice. Anadur has a high affinity towards the androgen receptor while having a lower androgenic expression, it is usually not recommended to be taken without testosterone. Without a high androgenic expression and having a strong bond to the AR, side effects of low testosterone are possible such as the infamous "Deca-Dick" (impotence), lethargy, and low sex drive.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL1871 Sources: https://www.steroid.com/Anadur.php |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sample Use Guides
In Vivo Use Guide
Sources: https://www.steroid.com/Anadur.php
Effective Dose (Men): 200-600 mgs/week (2mg/lb of Body weight); Effective Dose (Women): 50-100 mgs/week
Route of Administration:
Intramuscular
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:30:35 GMT 2025
by
admin
on
Mon Mar 31 19:30:35 GMT 2025
|
| Record UNII |
602JJC2862
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C2360
Created by
admin on Mon Mar 31 19:30:35 GMT 2025 , Edited by admin on Mon Mar 31 19:30:35 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
92341
Created by
admin on Mon Mar 31 19:30:35 GMT 2025 , Edited by admin on Mon Mar 31 19:30:35 GMT 2025
|
PRIMARY | |||
|
C95971
Created by
admin on Mon Mar 31 19:30:35 GMT 2025 , Edited by admin on Mon Mar 31 19:30:35 GMT 2025
|
PRIMARY | |||
|
m7720
Created by
admin on Mon Mar 31 19:30:35 GMT 2025 , Edited by admin on Mon Mar 31 19:30:35 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID20966654
Created by
admin on Mon Mar 31 19:30:35 GMT 2025 , Edited by admin on Mon Mar 31 19:30:35 GMT 2025
|
PRIMARY | |||
|
Nandrolone hexyloxyphenylpropionate
Created by
admin on Mon Mar 31 19:30:35 GMT 2025 , Edited by admin on Mon Mar 31 19:30:35 GMT 2025
|
PRIMARY | |||
|
257-810-4
Created by
admin on Mon Mar 31 19:30:35 GMT 2025 , Edited by admin on Mon Mar 31 19:30:35 GMT 2025
|
PRIMARY | |||
|
52279-57-9
Created by
admin on Mon Mar 31 19:30:35 GMT 2025 , Edited by admin on Mon Mar 31 19:30:35 GMT 2025
|
PRIMARY | |||
|
100000085690
Created by
admin on Mon Mar 31 19:30:35 GMT 2025 , Edited by admin on Mon Mar 31 19:30:35 GMT 2025
|
PRIMARY | |||
|
SUB03386MIG
Created by
admin on Mon Mar 31 19:30:35 GMT 2025 , Edited by admin on Mon Mar 31 19:30:35 GMT 2025
|
PRIMARY | |||
|
602JJC2862
Created by
admin on Mon Mar 31 19:30:35 GMT 2025 , Edited by admin on Mon Mar 31 19:30:35 GMT 2025
|
PRIMARY |